DHBUF:OTC-Delivra Health Brands Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 0.1267

Change

+0.11 (+744.67)%

Market Cap

USD 5.54M

Volume

1.36K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Delivra Health Brands Inc., through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide. The company offers cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It sells its products under LivRelief, Dream Water, and LivRelief infused brands. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+3.04 (+1.93%)

USD 74.41B
TAK Takeda Pharmaceutical Co Ltd A..

+0.20 (+1.44%)

USD 43.37B
HLN Haleon plc

+0.18 (+1.82%)

USD 43.18B
RDY Dr. Reddy’s Laboratories Ltd..

-0.09 (-0.67%)

USD 11.49B
ELAN Elanco Animal Health

-0.11 (-0.99%)

USD 5.69B
AMRX Amneal Pharmaceuticals, Inc. C..

-0.04 (-0.51%)

USD 3.63B
BHC Bausch Health Companies Inc

+0.13 (+1.81%)

USD 2.41B
CPHI China Pharma Holdings Inc

-0.01 (-4.59%)

USD 3.69M
YCBD cbdMD Inc

+0.01 (+1.47%)

USD 1.96M
EBS Emergent Biosolutions Inc

-0.13 (-1.66%)

N/A

ETFs Containing DHBUF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.29% 87% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.29% 87% B+ 85% B
Trailing 12 Months  
Capital Gain -54.75% 7% C- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -54.75% 7% C- 2% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 17.23% 69% C- 62% D
Dividend Return 17.23% 68% D+ 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 45.08% 71% C- 55% F
Risk Adjusted Return 38.21% 91% A- 75% C
Market Capitalization 5.54M 30% F 4% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.